4baseCare Raises about ₹50 Crores to Drive Personalized Cancer Care in Asia and Beyond
Written by Sirish Dixit
4baseCare secures about ₹50 Cr in funding led by Yali Capital to advance personalized cancer care across India, Asia, and the Middle East. The funds will enhance product offerings and address the critical genomic data gap in cancer treatment, according to CEO Hitesh Goswami.
Healthcare startup 4baseCare has secured approximately Rs 50 crore in a funding round led by Yali Capital, with plans to enhance its product offerings and expand operations across India, Asia, and the Middle East. The funding will allow 4baseCare to address key challenges in cancer care, particularly by leveraging genomic data to provide personalized treatments.
“Our mission has always been to close the critical genomic data gap in cancer care,” said Hitesh Goswami, Co-founder and CEO of 4baseCare. “This investment will allow us to enhance our offerings and bring personalized cancer care to millions of people, making advanced treatment more accessible and affordable.”
Alongside 4baseCare, MiClient, an AI-driven B2B sales enablement platform, has raised Rs 3.9 crore from IAN Group, Anicut, GSF, RTAF, and Keiretsu.
Swati Sharma, Co-founder and CEO of MiClient shared her excitement about the next phase of growth: “This new funding will help us expand our team, address key challenges faced by MSMEs/SMBs, and strengthen our market presence.”
Both 4baseCare and MiClient are at the forefront of innovation in their respective fields, with the backing of investors helping them scale their impact. These investments mark a significant milestone in driving advancements in personalized healthcare and AI-driven solutions across various sectors.